Search results for: 'rare ran'

25 Jun 2019  |  North America  |  Market Research

Global Rare Earth Materials Market, Forecast to 2025

The Rise in Neodymium Magnet, Lanthanum and Cerium-based Application Demand Contributes to Noteworthy Market Growth

Infographics

×

Key Issues Addressed

The seventeen rare-earth elements are cerium (Ce), dysprosium (Dy), erbium (Er), europium (Eu), gadolinium (Gd), holmium (Ho), lanthanum (La), lutetium (Lu), neodymium (Nd), praseodymium (Pr), promethium (Pm), samarium (Sm), scandium (Sc), terbium (Tb), thulium (Tm), ytterbium (Yb), and yttrium (Y). They find important applications in various indus...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

12 Aug 2020  |  North America  |  Market Research

New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025

AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities

Infographics

×

Key Issues Addressed

Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...

The fifth generation of wireless technology (5G) has arrived and is being rolled out globally. 5G is possible because of the contributions of previous generations of wireless communications and a number of disruptive technologies, each of which must be understood at least at a high level to paint a full picture of the industry. This report centers ...

This report focuses on the growth opportunities available to communication service providers (CSPs) and their suppliers by an evolving network technology: open and virtual radio access networks (RANs). To understand these opportunities, it is necessary to first describe where the mobile and wireless industry has been, where it is at now, and where ...

This report focuses on the growth opportunities that the fifth generation of wireless technology (5G) makes available to communication service providers (CSPs) and their suppliers, specifically regarding the 5G network infrastructure that is required to enable 5G communications. 5G is designed to build upon 4G. The first iterations of 5G NR that ar...

12 Jan 2021  |  North America  |  Frost Radar

Frost Radar™: 5G Network Infrastructure Market, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Infographics

×

Frost & Sullivan defines 5G network infrastructure to include radio access networks (RAN), transport networks, and core networks (which may include one or more edge networks). 5G introduces many disruptive technologies, from new chips and devices to new network architectures, that impact all areas of network infrastructure. The promise of 5G for ...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...